Vanguard Investments Australia
SANA icon

Vanguard Investments Australia’s Sana Biotechnology SANA Stock Holding History

Vanguard Investments Australia’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Hold
37,523
– – ﹤0.01% 2256
2026
Q1 		$108K Buy
+37,523
New +$148K ﹤0.01% 2257

Other funds holding SANA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Investments Australia's SANA Position: Q2 2026 in Review

Vanguard Investments Australia held its Sana Biotechnology (SANA) position steady in Q2 2026 at 37,523 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Vanguard Investments Australia first reported a position in SANA in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Vanguard Investments Australia held 37,523 shares of Sana Biotechnology worth $131K as of Q2 2026.
  • Vanguard Investments Australia left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2256 holding.
  • Vanguard Investments Australia first reported a position in Sana Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.